Mass General Brigham, Inc
- SEC CIK
- 0001678378
- Latest filing
- Aug 7, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Jul 31, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 4
- −1 vs. Q1 2024
- Portfolio value
- $20.5M
- −$36.6M (−64.0%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 338,191 | $13.1M | 63.9% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 288,690 | $3.10M | 15.1% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 354,192 | $3.04M | 14.8% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 205,356 | $1.27M | 6.2% | 00.0% | Unchanged | History |
Sold out since Q1 2024 (1)
Positions held at the end of Q1 2024 that are gone from this filing.